Quantitative prognostic indices in peritoneal carcinomatosis.

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Peritoneal carcinomatosis requires accurate staging for effective patient management.
• Several staging systems exist, but their combined utility is not fully explored.

Purpose of the Study:

• To describe and discuss five available staging systems for peritoneal carcinomatosis.
• To evaluate the benefit of combining these systems for prognostic assessment and treatment selection.

Main Methods:

• Review and description of the Lyon staging system.
• Review and description of the Peritoneal Cancer Index (PCI).
• Review and description of the Japanese Research Society for Gastric Cancer carcinomatosis staging (JRSGS).
• Review and description of the Dutch simplified peritoneal carcinomatosis assessment.
• Review and description of the Completeness of Cytoreduction Score (CCR).

Main Results:

• Five distinct staging systems for peritoneal carcinomatosis were identified and detailed.
• The study emphasizes the importance of these systems in describing peritoneal lesions before and after treatment.

Conclusions:

• Combining multiple staging systems provides a comprehensive description of peritoneal carcinomatosis.
• Integrated staging approaches improve prognostic accuracy and guide optimal treatment strategies for patients with peritoneal carcinomatosis.